Annual Operating Profit
-$310.37 M
-$5.55 M-1.82%
31 December 2023
Summary:
Pacific Biosciences of California annual operaing income is currently -$310.37 million, with the most recent change of -$5.55 million (-1.82%) on 31 December 2023. During the last 3 years, it has fallen by -$205.98 million (-197.33%). PACB annual operating profit is now -1226.86% below its all-time high of -$23.39 million, reached on 31 December 2007.PACB Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$62.91 M
+$19.74 M+23.88%
30 September 2024
Summary:
Pacific Biosciences of California quarterly operating income is currently -$62.91 million, with the most recent change of +$19.74 million (+23.88%) on 30 September 2024. Over the past year, it has increased by +$10.88 million (+14.74%). PACB quarterly operating profit is now -5823.45% below its all-time high of -$1.06 million, reached on 31 December 2015.PACB Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$313.37 M
+$10.88 M+3.35%
30 September 2024
Summary:
Pacific Biosciences of California TTM operating income is currently -$313.37 million, with the most recent change of +$10.88 million (+3.35%) on 30 September 2024. Over the past year, it has dropped by -$6.90 million (-2.25%). PACB TTM operating profit is now -1175.52% below its all-time high of -$24.57 million, reached on 30 September 2009.PACB TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PACB Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.8% | +14.7% | -2.3% |
| 3 y3 years | -197.3% | -43.8% | -125.4% |
| 5 y5 years | -207.3% | -123.8% | -176.7% |
PACB Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -197.3% | at low | -43.8% | +27.2% | -125.4% | +3.4% |
| 5 y | 5 years | -208.7% | at low | -251.1% | +27.2% | -218.7% | +3.4% |
| alltime | all time | -1226.9% | at low | -5823.4% | +27.2% | -1175.5% | +3.4% |
Pacific Biosciences Of California Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$62.91 M(-23.9%) | -$313.37 M(-3.4%) |
| June 2024 | - | -$82.65 M(+1.5%) | -$324.25 M(+3.7%) |
| Mar 2024 | - | -$81.43 M(-5.7%) | -$312.80 M(+0.8%) |
| Dec 2023 | -$310.37 M(+1.8%) | -$86.39 M(+17.1%) | -$310.37 M(+1.3%) |
| Sept 2023 | - | -$73.78 M(+3.6%) | -$306.47 M(+1.1%) |
| June 2023 | - | -$71.20 M(-9.9%) | -$303.02 M(-0.7%) |
| Mar 2023 | - | -$79.00 M(-4.2%) | -$305.23 M(+0.1%) |
| Dec 2022 | -$304.82 M(+71.1%) | -$82.49 M(+17.3%) | -$304.82 M(+6.8%) |
| Sept 2022 | - | -$70.34 M(-4.2%) | -$285.46 M(+10.3%) |
| June 2022 | - | -$73.41 M(-6.6%) | -$258.87 M(+16.1%) |
| Mar 2022 | - | -$78.59 M(+24.5%) | -$223.04 M(+25.2%) |
| Dec 2021 | -$178.16 M(+70.7%) | -$63.13 M(+44.3%) | -$178.16 M(+28.2%) |
| Sept 2021 | - | -$43.75 M(+16.4%) | -$139.01 M(+16.4%) |
| June 2021 | - | -$37.57 M(+11.5%) | -$119.44 M(+13.3%) |
| Mar 2021 | - | -$33.71 M(+40.6%) | -$105.39 M(+1.0%) |
| Dec 2020 | -$104.39 M(+3.8%) | -$23.98 M(-0.8%) | -$104.39 M(+6.2%) |
| Sept 2020 | - | -$24.18 M(+2.8%) | -$98.33 M(-3.9%) |
| June 2020 | - | -$23.52 M(-28.1%) | -$102.26 M(-0.8%) |
| Mar 2020 | - | -$32.71 M(+82.6%) | -$103.12 M(+2.6%) |
| Dec 2019 | -$100.55 M(-0.4%) | -$17.92 M(-36.3%) | -$100.55 M(-11.2%) |
| Sept 2019 | - | -$28.11 M(+15.3%) | -$113.25 M(+3.1%) |
| June 2019 | - | -$24.38 M(-19.1%) | -$109.81 M(+2.5%) |
| Mar 2019 | - | -$30.13 M(-1.6%) | -$107.17 M(+6.1%) |
| Dec 2018 | -$100.99 M(+12.5%) | -$30.62 M(+24.1%) | -$100.99 M(+11.1%) |
| Sept 2018 | - | -$24.67 M(+13.5%) | -$90.89 M(+3.5%) |
| June 2018 | - | -$21.75 M(-9.2%) | -$87.79 M(-2.9%) |
| Mar 2018 | - | -$23.95 M(+16.7%) | -$90.43 M(+0.7%) |
| Dec 2017 | -$89.78 M(+26.0%) | -$20.53 M(-4.8%) | -$89.78 M(+3.0%) |
| Sept 2017 | - | -$21.57 M(-11.6%) | -$87.13 M(+5.9%) |
| June 2017 | - | -$24.39 M(+4.7%) | -$82.30 M(+8.3%) |
| Mar 2017 | - | -$23.30 M(+30.4%) | -$75.98 M(+6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$71.24 M(+36.5%) | -$17.87 M(+6.8%) | -$71.24 M(+30.9%) |
| Sept 2016 | - | -$16.73 M(-7.4%) | -$54.43 M(-6.4%) |
| June 2016 | - | -$18.07 M(-2.7%) | -$58.13 M(+13.1%) |
| Mar 2016 | - | -$18.57 M(+1648.1%) | -$51.41 M(-1.5%) |
| Dec 2015 | -$52.18 M(-17.0%) | -$1.06 M(-94.8%) | -$52.18 M(-24.4%) |
| Sept 2015 | - | -$20.43 M(+79.9%) | -$69.01 M(+21.1%) |
| June 2015 | - | -$11.36 M(-41.2%) | -$56.99 M(-10.9%) |
| Mar 2015 | - | -$19.33 M(+8.0%) | -$63.94 M(+1.7%) |
| Dec 2014 | -$62.85 M(-18.9%) | -$17.89 M(+112.7%) | -$62.85 M(+1.4%) |
| Sept 2014 | - | -$8.41 M(-54.0%) | -$61.96 M(-15.7%) |
| June 2014 | - | -$18.30 M(+0.3%) | -$73.49 M(-2.3%) |
| Mar 2014 | - | -$18.25 M(+7.3%) | -$75.18 M(-3.0%) |
| Dec 2013 | -$77.54 M(-17.8%) | -$17.00 M(-14.7%) | -$77.54 M(-5.7%) |
| Sept 2013 | - | -$19.93 M(-0.3%) | -$82.23 M(-3.1%) |
| June 2013 | - | -$20.00 M(-3.0%) | -$84.88 M(-2.9%) |
| Mar 2013 | - | -$20.61 M(-5.0%) | -$87.44 M(-7.3%) |
| Dec 2012 | -$94.34 M(-14.0%) | -$21.69 M(-3.9%) | -$94.34 M(-1.0%) |
| Sept 2012 | - | -$22.58 M(+0.1%) | -$95.33 M(-6.7%) |
| June 2012 | - | -$22.55 M(-18.0%) | -$102.19 M(-0.1%) |
| Mar 2012 | - | -$27.51 M(+21.2%) | -$102.30 M(-6.8%) |
| Dec 2011 | -$109.76 M(-21.7%) | -$22.69 M(-22.9%) | -$109.76 M(-11.2%) |
| Sept 2011 | - | -$29.44 M(+29.9%) | -$123.66 M(-8.3%) |
| June 2011 | - | -$22.66 M(-35.2%) | -$134.91 M(-6.9%) |
| Mar 2011 | - | -$34.97 M(-4.4%) | -$144.93 M(+3.3%) |
| Dec 2010 | -$140.23 M(+59.2%) | -$36.59 M(-10.1%) | -$140.23 M(+6.5%) |
| Sept 2010 | - | -$40.70 M(+24.5%) | -$131.72 M(+14.0%) |
| June 2010 | - | -$32.67 M(+7.9%) | -$115.59 M(+39.4%) |
| Mar 2010 | - | -$30.27 M(+7.8%) | -$82.92 M(+57.5%) |
| Dec 2009 | -$88.07 M(+96.5%) | -$28.07 M(+14.3%) | -$52.64 M(+114.3%) |
| Sept 2009 | - | -$24.57 M | -$24.57 M |
| Dec 2008 | -$44.81 M(+91.6%) | - | - |
| Dec 2007 | -$23.39 M | - | - |
FAQ
- What is Pacific Biosciences of California annual operaing income?
- What is the all time high annual operating profit for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual operating profit year-on-year change?
- What is Pacific Biosciences of California quarterly operating income?
- What is the all time high quarterly operating profit for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly operating profit year-on-year change?
- What is Pacific Biosciences of California TTM operating income?
- What is the all time high TTM operating profit for Pacific Biosciences of California?
- What is Pacific Biosciences of California TTM operating profit year-on-year change?
What is Pacific Biosciences of California annual operaing income?
The current annual operating profit of PACB is -$310.37 M
What is the all time high annual operating profit for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual operaing income is -$23.39 M
What is Pacific Biosciences of California annual operating profit year-on-year change?
Over the past year, PACB annual operaing income has changed by -$5.55 M (-1.82%)
What is Pacific Biosciences of California quarterly operating income?
The current quarterly operating profit of PACB is -$62.91 M
What is the all time high quarterly operating profit for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly operating income is -$1.06 M
What is Pacific Biosciences of California quarterly operating profit year-on-year change?
Over the past year, PACB quarterly operating income has changed by +$10.88 M (+14.74%)
What is Pacific Biosciences of California TTM operating income?
The current TTM operating profit of PACB is -$313.37 M
What is the all time high TTM operating profit for Pacific Biosciences of California?
Pacific Biosciences of California all-time high TTM operating income is -$24.57 M
What is Pacific Biosciences of California TTM operating profit year-on-year change?
Over the past year, PACB TTM operating income has changed by -$6.90 M (-2.25%)